ClinicalTrials.Veeva

Menu

A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People (ProMuscle)

W

Wageningen University

Status

Completed

Conditions

Sarcopenia

Treatments

Dietary Supplement: Placebo drink
Other: Resistance exercise training
Dietary Supplement: Protein drink

Study type

Interventional

Funder types

Other

Identifiers

NCT01110369
A1002-2

Details and patient eligibility

About

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.

Enrollment

62 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Frail elderly individuals
  • Able to understand and perform the study procedures

Exclusion criteria

  • Type I or type II diabetes (fasted blood glucose level ≥7,0 mmol)
  • No recent history (within 2 years) of participating in any regular resistance exercise training program (general questionnaire)
  • Use of anti-coagulation medication (except of Acetyl Salicyl acid)
  • Presence of coronary heart disease (ECG)
  • Renal insufficiency (eGFR <60 mL/min/1.73 m2)
  • Allergic or sensitive for milk proteins

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

62 participants in 2 patient groups, including a placebo group

Resistance exercise training and protein drink
Experimental group
Treatment:
Dietary Supplement: Protein drink
Other: Resistance exercise training
Resistance exercise training and placebo drink
Placebo Comparator group
Treatment:
Other: Resistance exercise training
Dietary Supplement: Placebo drink

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems